Respond promptly per plan procedures with medical necessity criteria; log the request and response date.
If DOL finds your NQTL analysis deficient, you have 45 days to resubmit a corrected version.
Refresh NQTL analyses before each plan year and whenever benefits, vendors, or prior-auth rules change.
| Trigger | Due Date / Window | Notes |
|---|---|---|
| Participant request for MH/SUD medical necessity criteria | Promptly per plan procedures | Have standard response language ready; log the request and response date. |
| MH/SUD claim denial | With the denial notice | State the specific denial reason; follow ERISA claims and appeals procedures. |
| DOL/regulator request for NQTL analysis | Provide upon request; 45 calendar days to correct if deficient | If DOL finds the analysis deficient, you have 45 days to resubmit a corrected version. If still non-compliant after that, you must notify plan participants within 7 calendar days of the final determination. |
| Annual internal review (best practice) | Before each plan year | Refresh NQTL analyses whenever benefits, vendors, or prior-auth rules change. |
- Medical necessity criteria for all MH/SUD benefits, and a documented process for how participants can request them.
- NQTL comparative analysis covering each non-quantitative treatment limit your plan uses (e.g., prior authorization, step therapy, network admission standards, out-of-network reimbursement rates, medical management programs). This is the document DOL will request in an audit.
- Claims and appeals templates with specific denial-reason language for MH/SUD claim denials.
- Response workflow: Who handles information requests, what the turnaround target is, and where the NQTL analysis is stored and version-controlled.
- Method: Paper or electronic. For electronic delivery to participants, follow ERISA e-disclosure practices (consent or electronic-access criteria).
- Privacy: MH/SUD information may involve PHI; use secure delivery channels and limit access to those who need it.
- Clarity: Plain language. Include the specific information requested, the source (e.g., which NQTL or criteria document), and a contact name for follow-up questions.
- Disclosure responsesCopies of each disclosure response and the materials provided, date-stamped.
- Request logDate received, requester name and relationship to the plan, method of delivery, who fulfilled the request, and date sent.
- NQTL analysisCurrent comparative analysis with version history; keep prior versions so you can show what was in place at any given point in time.
- Training recordsFor staff who handle parity information requests.
- Regulator correspondenceAny DOL or regulator correspondence, including audit request letters and your responses.
Common traps
FAQs
Do we have to mail an MHPAEA notice every year?
No. MHPAEA does not require a periodic standalone notice. Your obligations are to provide medical necessity criteria and parity-related information upon request, follow ERISA claims and appeals rules for MH/SUD denials, and maintain a current NQTL comparative analysis.
Who prepares the NQTL comparative analysis?
For insured plans, carriers often prepare it, but request a copy and confirm it covers your specific plan design. For self-funded plans, the plan sponsor (with the TPA and typically ERISA counsel) is responsible. Start with the DOL Self-Compliance Tool in the Key Resources section below.
What do we send when a participant asks?
The applicable medical necessity criteria for the MH/SUD benefit in question, plus any other parity-related information appropriate to the request. For claim denials, the specific denial reason is required with the denial notice under ERISA claims and appeals rules.
- MHPAEA, DOL EBSA. The main hub for regulations, guidance, enforcement data, and employer resources.
- MHPAEA FAQs Part 45, DOL EBSA (PDF). Agency Q&As on parity requirements, NQTL analysis, and plan obligations under CAA 2021.
- Fact Sheet: 2024 Final MHPAEA Rules, DOL EBSA. Summary of the new requirements and their staggered effective dates.
- Carve-out vendors: If your plan uses separate vendors for medical, MH/SUD, and pharmacy (PBM), parity must be assessed across all three. Coordinate to ensure NQTLs, especially prior authorization and network admission standards, are consistent across benefits.
- Small-group insured plans: Federal MHPAEA applies to large-group plans; small-group insured plans follow parity requirements through state law and ACA market reforms. Confirm specifics with your carrier.
- Plan changes: Any time you add or modify an NQTL (new prior-authorization requirements, network tier changes, step therapy protocols), the NQTL analysis must be updated before the change takes effect.
- 2024 Final Rule enforcement status: On September 9, 2024, DOL/HHS/Treasury finalized new MHPAEA rules with staggered effective dates (plan years starting January 1, 2025 and January 1, 2026). Due to pending litigation, the Departments have paused enforcement of the provisions that are new relative to the 2013 rule. The underlying 2013 MHPAEA requirements and the CAA 2021 NQTL analysis mandate remain fully enforceable. Monitor DOL guidance for updates as litigation progresses.
Start with the DOL Self-Compliance Tool before your next plan-year review; it's the fastest way to identify NQTL gaps before a DOL auditor does.
- MHPAEA Self-Compliance Tool (DOL PDF). The DOL's primary framework for evaluating NQTL compliance. Work through it with your TPA or carrier to document whether your plan's MH/SUD treatment limits are truly comparable to medical/surgical limits. If you don't have a written NQTL analysis, this is where to start.
- Warning Signs: NQTLs That Require Additional Analysis (DOL). A plain-language guide identifying the types of treatment limits most likely to fail parity review. Review this against your plan's prior authorization, network, step therapy, and medical management rules before an audit arrives.
- DOL Enforcement Statement, 2024 Final Rule. The Departments' official statement on which provisions of the 2024 Final Rule are currently subject to enforcement and which are paused pending litigation.